HKEX: 3692 - Hansoh Pharmaceutical Group Company Limited

Altı ay boyunca karlılık: +1.89%
Temettü getirisi: +2.02%
Sektör: Healthcare

Promosyon programı Hansoh Pharmaceutical Group Company Limited


Şirket hakkında Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited, инвестиционная холдинговая компания, занимается исследованием, разработкой, производством и продажей фармацевтической продукции в Китайской Народной Республике. Компания предоставляет продукты для терапевтических областей, в том числе противоопухолевых, противоинфекционных, заболеваний центральной нервной системы, метаболических заболеваний и других терапевтических областей.

daha fazla ayrıntı
Его основные продукты включают препараты Mailingda, Ameile, Hansoh Xinfu, Fulaimei, Hengmu, Xinwei, Tanneng, Ameining, Oulanning, Ailanning, Zetan, Ruibote, Fulaidi, Puruian, Fulairui, Pulaile, Zefei, Xinmei, Xintai и Gainuo, а также СИНЬЮЭ и Хенгсен. Компания обслуживает дистрибьюторов фармацевтической продукции. Он сотрудничает с NiKang Therapeutics для разработки и коммерциализации NKT2152; TiumBio для разработки и коммерциализации TU2670 для лечения эндометриоза, миомы матки и других показаний; Глобальный институт медицинских открытий для разработки, производства и коммерциализации серии GDI-4405 против нового коронавируса; KiOmed Pharma SA для разработки и коммерциализации KiOmedinevsOne для лечения остеоартрита; и Biotheus Inc. для разработки и коммерциализации PM1080. Компания была основана в 1995 году и имеет штаб-квартиру в Шанхае, Китайская Народная Республика. Hansoh Pharmaceutical Group Company Limited является дочерней компанией Stellar Infinity Company Ltd.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

ISIN KYG549581067
Industry Pharmaceuticals
Sector Health Care
Валюта hkd
Валюта отчета cny
Див.доход ао 2.31
Дивиденд ао 0.3432
Сайт https://www.hspharm.com
Цена ао 18.32
Günlük fiyat değişimi: -0.6508% (18.44)
Haftalık fiyat değişimi: +6.39% (17.22)
Aylık fiyat değişimi: +6.39% (17.22)
3 ayda fiyat değişimi: +0.3286% (18.26)
Altı ayda fiyat değişimi: +1.89% (17.98)
Yıllık fiyat değişimi: +35.5% (13.52)
3 yılda fiyat değişimi: +8.27% (16.92)
5 yılda fiyat değişimi: -28.02% (25.45)
10 yılda fiyat değişimi: 0% (18.32)
Yılbaşından bu yana fiyat değişimi: +2.92% (17.8)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 7.55 1
P/BV 2.96 6
P/E 23.28 6
EV/EBITDA 25.04 4
Toplam: 5.75

Yeterlik

İsim Anlam Seviye
ROA, % 10.4 4
ROE, % 13.53 4
Toplam: 4.33

Temettüler

İsim Anlam Seviye
Div yield, % 2.02 5.05
DSI 1 10
Toplam: 6.14

Görev

İsim Anlam Seviye
Debt/EBITDA 1.31 8
Toplam: 8.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 16.37 3
karlılık Ebitda, % 45.16 6
karlılık EPS, % 1074.7 10
Toplam: 4.8
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Fidelity Advisor Focused Emerging Markets Fund 34306000 0.58
Fidelity Strategic Advisors Fidelity Emerging Markets Fund 17134000 0.29
Vanguard International Stock Index-Emerging Markets Stk 13235000 0.22
Vanguard International Stock Index-Total Intl Stock Indx 13095836 0.22
Fidelity Series Emerging Markets Opportunities Fund 10250000 0.17
iShares Core MSCI Emerging Markets ETF 10204000 0.17
Fidelity VIP Emerging Markets Portfolio 9078000 0.15
Fidelity Strategic Advisers Emerging Markets Fund 7653744 0.13
Fidelity Emerging Markets Discovery Fund 7410308 0.12
iShares MSCI China ETF 3556000 0.06

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
Loncar China BioPharma ETF 2.19 18434.25
KraneShares MSCI All China Health Care Index ETF 1.58339 15.16 2.31691
Global X Aging Population ETF 1.24142 20.37 1.46713
FlexShares International Quality Dividend Dynamic Index Fund 0.82555 12.66 5.93365
Nuveen ESG Emerging Markets Equity ETF 0.31255 11.62 2.89278
Avantis Emerging Markets Value ETF 0.26556 14.12 4.22231
WisdomTree China ex-State-Owned Enterprises Fund 0.23369 13.84 2.29363
Franklin FTSE China ETF 0.13013 14.5 3.35323
FINEX CHINA UCITS ETF 0.13 -34.73
SPDR S&P China ETF 0.10157 17.02 3.40103
Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF 0.07086 17.59 2.86877
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.05765 14.02 2.84808
Avantis Emerging Markets Equity ETF 0.05491 8.77 3.60513
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.04687 9.13 3.47133
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.0409 15.84 3.04307
John Hancock Multifactor Emerging Markets ETF 0.03921 4.68 3.42078
Avantis Responsible Emerging Markets Equity ETF 0.03118 17.6 3.1719
Franklin FTSE Asia ex Japan ETF 0.0274 14.43 2.66768
SPDR MSCI ACWI Climate Paris Aligned ETF 0.01526 25.32 1.86415
Dimensional Emerging Markets Core Equity 2 ETF 0.01498 15.96 3.34087
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01317 12.46 3.59676
SPDR Portfolio Emerging Markets ETF 0.01297 11.59 3.1879
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01273 18.18 3.26685
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
iShares MSCI ACWI ETF 0.00442 -19.68 2.10908
Dimensional International Small Cap ETF 0.00439 5.69 3.34747
Dimensional World ex U.S. Core Equity 2 ETF 0.00216 13.06 3.62488
Dimensional International Core Equity Market ETF 0.00035 13.09 3.48343



Süpervizör İş unvanı Ödeme Doğum yılı
Ms. Huijuan Zhong Chairlady, CEO & President 12.07M 1961 (64 yıl)
Mr. Min Hu VP & CFO N/A 1977 (48 yıllar)
Ms. Yuan Sun Executive Director 7.43M 1987 (38 yıllar)
Mr. Chuanhe Xu Senior Vice President N/A 1964 (61 yıl)
Mr. Weiyong Sun Chief Commercial Officer N/A 1971 (54 yıl)
Dr. Aifeng Lyu Executive Director 1977 (48 yıllar)
Dr. Chih-Hung Lee Chief of Science Officer 1960 (65 yıllar)
Ms. Shengli Zhong Joint Company Secretary & Senior VP 1968 (57 yıllar)
Ms. Sze Wai Tam Joint Company Secretary

Adres: China, Shanghai, 287 Xiangke Road - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.hspharm.com